Lab 2.0 Interface

If you’re not using the New Kipu 2.0 Lab Interface, you’re missing a whole new way to streamline your treatment center and simplify lab ordering, collection, and results. Now includes Chain Of Custody and MNDR Reporting!

Collect, Process and Ship

Requisition comes up in system to collect a sample based on schedule or at random. Collect. Add Label. Scan. Ship/Pick up. Chain of Custody Tracked.

Kipu Lab Interface Documents

Patient demographic information
Prescribed medications
Diganosis codes
Insurance information

Specimen Testing

Specimen is collected
Label automatically generated
Label is scanned
Specimen shipped or picked up

  • Kipu’s Lab Interface Documents

  • Specimen Testing

  • Now Supports Dymo Printers

Receive Results

Arrives at lab, lab performs ordered tests. Lab returns results. This icon       appears on the home screen to indicate that there is an un-reviewed lab result.

Review and sign results. Order a re-test if needed. Change treatment plan.

Connects through the “Golden Thread.”

  • Lab returns lab results directly into patient file

  • Notification of unreviewed lab result

  • Review and sign

  • So new, we’re filing for a provisional patent

Receive Reports

  • MNDR (Medical Necessity Documentation Report)

  • Report on Orders Per Patient

  • Report on Requisitions Per Patient

  • Report on Results Per Patient

Now Supports Dymo Printer! The industry standard Dymo 450

Currently interfaced with 90 Toxicology labs, 20 Clinical labs, DNA Pharmacogenomics, and e-Prescribe systems.

Review and sign results. Order a re-test if needed. Change treatment plan.   Connects through the “Golden Thread.”

Order Tests

No more paper forms, double entry or errors

  • Specify Test Frequencies

  • Generate Random Test Frequencies

  • Narrative Builder for Statements of Medical Necessity

  • No need to log into separate portals to input data

  • Physician’s orders are transmitted automatically

  • Assists in compliance

  • Eliminates the possibility of overtesting or missing test

See The New Lab 2.0 Features!

See Full MNDR Report

New Lab 2.0 Features

New Lab 2.0 Features

KIPU’s powerful HL7 lab and analyzer interfaces allow your medical personnel to place orders for testing, process requisitions, and receive lab results directly into the patient chart, saving you countless hours and effort spent faxing, reviewing, and scanning paper reports. In fact, Kipu has partnered with over 90 testing labs in order to process orders and results electronically. This is done via Kipu’s optional customizable lab interface. The lab interface enables substance abuse facilities to order, collect and receive lab results all within the same seamless interface.

Lab Test Templates

Simply go to Templates/Lab Test Profiles and click on New Lab Test Profile.

Enter a name for the profile. Examples:

  • Cocaine Quantification

  • Cocaine Screen

  • Cocaine Confirm Positive

  • Cocaine Confirm Negative

Click on Active

Once you have finished with this template, click Create.

You can create custom Lab Test Profiles that reflect your organization’s specific needs and abide by your P&Ps (Policies and Procedures), and truly customize the treatment to your patients’ needs. This feature supports Toxicology, Clinical (bloodwork), Pharmacogenetic and Hair Segmentation Lab tests.

You can create as many custom Lab Test Profiles from your lab providers’ compendiums (menus) of tests as you need.

Start typing the name of the lab tests you want to include in this profile and select from your lab’s offerings. Repeat this procedure to add as many tests as you need. Please have in mind that some labs offer several options for each test and you will need to choose one, as choosing more would be a contradictory order, and the lab will not be able to proceed with the testing.

Urine Drug Testing

Urine drug tests include two different types of tests:

  • The first type of test produces “qualitative” or “presumptive” results; that is, the results indicate that the sample is positive or negative for specified classes of drugs. These tests can be performed under a certificate of waiver or a certificate of accreditation, depending on the equipment and the methodology used.

  • The second type of test produces “quantitative” or “definitive” results; that is, the results indicate the specific substance or drug and the quantity of the substance or drug in the sample. The quantitative test is a more sophisticated test that requires the laboratory to use costly, highly complex equipment. In order to perform these types of tests in a medical clinic, the clinic must possess a CLIA certificate of accreditation.

While UDTs and UDSs can play an important role in mental health and substance abuse treatment, a physician must make an individualized, patient-specific determination about the frequency of testing and the types of drugs to be tested in order for the testing to be considered medically necessary.

Because the drug testing must be tailored to each patient’s particular medical needs, standard panels of tests and testing at set intervals (such as at every designated office visit) may not be considered medically necessary. Always follow your organization’s Policies and Procedures, and consult with your ordering Physician and Compliance officer.

KIPU allows you to create local profile templates with your lab’s test offerings*, where you can narrow down your ordering, and tailor it to each patient, for example:

  • Comprehensive Intake Panel

  • Alcohol and other sedatives

  • Opiates and Opioids

  • Stimulants

  • Designer drugs, and more

*To better understand the lab’s test offerings, please contact your lab representative.

You can also customize as many Statements of Medical Necessity (SOMN™) as needed to better reflect the need for each order and avoid the appearance of cookie-cutter testing; for example:

  • SOMN for Intake testing

  • SOMN for Alcohol/sedative testing

  • SOMN for Opiate/Opioid testing

  • SOMN for Stimulant testing

  • SOMN for Designer Drug testing

When receiving a lab result, following your Policies and Procedures, the ordering Physician will need to sign the result, and may write a review note at the time of signing.

Hair Drug Testing

Kipu now offers Laboratory Interfaces for both Hair Drug Testing and Segmented Hair Drug Testing.

Thanks to the overwhelming success of Kipu’s Bi-directional (orders and results), Toxicology and Clinical Laboratory interfaces, we’re proud to announce two new interfaces for Hair Drug Testing and Segmented Hair Drug Testing. These new interfaces are already supported by a dozen Reference Labs and generate the same Statements of Medical Necessity and Medical Necessity Documentation Report (MNDR).